Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy

摘要

BackgroundBelatacept is a novel immunosuppressive therapy designed to improve clinical outcomes associated with kidney transplant recipients while minimizing use of calcineurin inhibitors (CNIs).